Biomaterial-based scaffold for in situ chemo-immunotherapy to treat poorly immunogenic tumors
The immunosuppressive tumour microenvironment impairs immunotherapy in poorly immunogenic cancer. Here, the authors load an alginate gel with GM-CSF, CpG oligonucleotides and doxorubicin-iRGD to promote immunogenic death of tumour cells and improve immunotherapy efficacy in triple negative breast ca...
Guardado en:
Autores principales: | Hua Wang, Alexander J. Najibi, Miguel C. Sobral, Bo Ri Seo, Jun Yong Lee, David Wu, Aileen Weiwei Li, Catia S. Verbeke, David J. Mooney |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2af10e759cc3482da0ca26d55a1844d7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Dramatic response of metaplastic breast cancer to chemo-immunotherapy
por: Sylvia Adams
Publicado: (2017) -
Co-delivery of IOX1 and doxorubicin for antibody-independent cancer chemo-immunotherapy
por: Jing Liu, et al.
Publicado: (2021) -
The Emerging Role of Decellularized Plant-Based Scaffolds as a New Biomaterial
por: Ashlee F. Harris, et al.
Publicado: (2021) -
Constructing a cell microenvironment with biomaterial scaffolds for stem cell therapy
por: Xiaotong Zhao, et al.
Publicado: (2021) -
Synergistic effect of tumor chemo-immunotherapy induced by leukocyte-hitchhiking thermal-sensitive micelles
por: Jing Qi, et al.
Publicado: (2021)